| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 41 |
| 1 | ADALIMUMAB | 38 |
| 2 | CYPROHEPTADINE HYDROCHLORIDE | 37 |
| 3 | METHOTREXATE SODIUM | 37 |
| 4 | OMEPRAZOLE MAGNESIUM | 37 |
| 5 | PREDNISONE | 37 |
| 6 | TOCILIZUMAB | 36 |
| 7 | METHOTREXATE | 34 |
| 8 | OMEPRAZOLE | 34 |
| 9 | ERGOCALCIFEROL | 31 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CYPROHEPTADINE HYDROCHLORIDE | 37 | 0.0082 |
| 1 | PAMIDRONATE DISODIUM | 20 | 0.0059 |
| 2 | ERGOCALCIFEROL | 31 | 0.0010 |
| 3 | ONASEMNOGENE ABEPARVOVEC-XIOI | 2 | 0.0009 |
| 4 | DEFLAZACORT | 2 | 0.0008 |
| 5 | SELUMETINIB | 1 | 0.0006 |
| 6 | ADALIMUMAB-FKJP | 26 | 0.0006 |
| 7 | ADALIMUMAB-AATY | 26 | 0.0005 |
| 8 | TOFACITINIB CITRATE | 7 | 0.0005 |
| 9 | ADALIMUMAB-ADAZ | 26 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 42 |
| 1 | Corticosteroid [EPC] | 40 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 36 |
| 3 | Proton Pump Inhibitor [EPC] | 36 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 34 |
| 5 | Provitamin D2 Compound [EPC] | 31 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 27 |
| 7 | Janus Kinase Inhibitor [EPC] | 7 |
| 8 | Vitamin B12 [EPC] | 3 |
| 9 | Vitamin C [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 31 | 0.0010 |
| 1 | Interleukin-6 Receptor Antagonist [EPC] | 36 | 0.0003 |
| 2 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 3 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 2 | 0.0002 |
| 4 | Selective T Cell Costimulation Modulator [EPC] | 27 | 0.0002 |
| 5 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |
| 6 | Antisense Oligonucleotide [EPC] | 1 | 0.0001 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 34 | 0.0001 |
| 8 | Proton Pump Inhibitor [EPC] | 36 | 0.0001 |
| 9 | Janus Kinase Inhibitor [EPC] | 7 | 0.0000 |